Cargando…

A Multi-Element Expression Score Is A Prognostic Factor In Glioblastoma Multiforme

PURPOSE: Glioblastoma multiforme (GBM) is a highly malignant tumor of the central nervous system. Although primary GBM patients receive extensive therapies, tumors may recur within months, and there is no objective and scientific method to predict prognosis. Adoptive immunotherapy holds great promis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jun-Qi, Wang, Qian-Ting, Nie, Ying, Xiao, Yun-Peng, Lin, Tao, Han, Ru-Jin, Li, Zhe, Fan, Yu-Ying, Yuan, Xiao-Hui, Wang, Yue-Ming, Zhang, Jian, He, You-Wen, Liao, Hua-Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805247/ https://www.ncbi.nlm.nih.gov/pubmed/31695490 http://dx.doi.org/10.2147/CMAR.S228174

Ejemplares similares

A Ferroptosis-Related Prognostic Risk Score Model to Predict Clinical Significance and Immunogenic Characteristics in Glioblastoma Multiforme
por: Xiao, Dongdong, et al.
Publicado: (2021)

Proteogenomic characterization and integrative analysis of glioblastoma multiforme
por: Song, Ying-Chun, et al.
Publicado: (2017)

TSPAN4 is a prognostic and immune target in Glioblastoma multiforme
por: Zheng, Yue, et al.
Publicado: (2023)

MRI Manifestions Correlate with Survival of Glioblastoma Multiforme Patients
por: Li, Wen-bin, et al.
Publicado: (2012)

Glioblastoma Multiforme
por: Sheehan, Jonas M., et al.
Publicado: (2012)

Identification of LOX as a candidate prognostic biomarker in Glioblastoma multiforme
por: Liu, Erheng, et al.
Publicado: (2023)

miR-340 suppresses glioblastoma multiforme
por: Huang, Daquan, et al.
Publicado: (2015)

Prognostic and Predictive Value of an Immunoscore Signature in Glioblastoma Multiform
por: Tang, Xiangjun, et al.
Publicado: (2020)

Construction of m6A-Related lncRNA Prognostic Signature Model and Immunomodulatory Effect in Glioblastoma Multiforme
por: Xie, Pan, et al.
Publicado: (2022)

Apatinib for recurrent/progressive glioblastoma multiforme: A salvage option
por: Zhang, Hong-Hong, et al.
Publicado: (2022)

Current Immunotherapies for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2021)

A new prognostic model for glioblastoma multiforme based on coagulation-related genes
por: Zhou, Min, et al.
Publicado: (2023)

Development of an Immune Infiltration-Related Prognostic Scoring System Based on the Genomic Landscape Analysis of Glioblastoma Multiforme
por: Tang, Guihua, et al.
Publicado: (2020)

Glioblastoma multiforme – an overview
por: Urbańska, Kaja, et al.
Publicado: (2014)

Incidentalomas to glioblastoma multiforme
por: Sachdev, Bobby, et al.
Publicado: (2014)

The clinical significance of glutathione peroxidase 2 in glioblastoma multiforme
por: Guo, Bangming, et al.
Publicado: (2021)

A risk signature with four autophagy‐related genes for predicting survival of glioblastoma multiforme
por: Wang, Yulin, et al.
Publicado: (2020)

Integrative Analyses and Verification of the Expression and Prognostic Significance for RCN1 in Glioblastoma Multiforme
por: Lu, Weicheng, et al.
Publicado: (2021)

BCNU for recurrent glioblastoma multiforme: efficacy, toxicity and prognostic factors
por: Reithmeier, Thomas, et al.
Publicado: (2010)

Prognostic Relevance of Cytochrome c Oxidase in Primary Glioblastoma Multiforme
por: Griguer, Corinne E., et al.
Publicado: (2013)

Heterogeneity of tumor-infiltrating lymphocytes ascribed to local immune status rather than neoantigens by multi-omics analysis of glioblastoma multiforme
por: Feng, Lin, et al.
Publicado: (2017)

Comprehensive portrait of recurrent glioblastoma multiforme in molecular and clinical characteristics
por: Li, Rui, et al.
Publicado: (2015)

Comprehensive Analysis of the Brain-Expressed X-Link Protein Family in Glioblastoma Multiforme
por: Aisa, Adilai, et al.
Publicado: (2022)

Integrated Analysis to Evaluate the Prognostic Value of Signature mRNAs in Glioblastoma Multiforme
por: Yang, Ji’an, et al.
Publicado: (2020)

Developing the novel bioinformatics algorithms to systematically investigate the connections among survival time, key genes and proteins for Glioblastoma multiforme
por: You, Yujie, et al.
Publicado: (2020)

Low-Intensity Focused Ultrasound Technique in Glioblastoma Multiforme Treatment
por: Mungur, Rajneesh, et al.
Publicado: (2022)

Glioblastoma multiforme: Diagnosis, treatment, and invasion
por: Li, Jiawei, et al.
Publicado: (2023)

ATF4-dependent fructolysis fuels growth of glioblastoma multiforme
por: Chen, Chao, et al.
Publicado: (2022)

Comprehensive Analysis of CD163 as a Prognostic Biomarker and Associated with Immune Infiltration in Glioblastoma Multiforme
por: Li, Hao, et al.
Publicado: (2021)

Dendritic Cell-Based Immunotherapy Treatment for Glioblastoma Multiforme
por: Yang, Liu, et al.
Publicado: (2015)

Prognostic significance of contactin 3 expression and associated genes in glioblastoma multiforme
por: Zhu, Yi-Fang, et al.
Publicado: (2019)

Prognostic Factors of Survival in Glioblastoma Multiforme Patients—A Retrospective Study
por: Șerban, Georgiana, et al.
Publicado: (2022)

Tectal plate glioblastoma multiforme
por: Nemer, Michael D., et al.
Publicado: (2011)

Bilateral cystic glioblastoma multiforme
por: Kumar, Sushil, et al.
Publicado: (2013)

Glioblastoma Multiforme Stem Cells
por: Dimov, Irena, et al.
Publicado: (2011)

Atypical Presentation of Glioblastoma Multiforme
por: Al-Janabi, Wissam, et al.
Publicado: (2018)

Nanotechnology for Treatment of Glioblastoma Multiforme
por: Michael, Justin S., et al.
Publicado: (2018)

The complement system in glioblastoma multiforme
por: Bouwens van der Vlis, T. A. M., et al.
Publicado: (2018)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

Survival Analysis of Glioblastoma Multiforme
por: Witthayanuwat, Supapan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dnk6jfg2ijqbk4ucg9faceabq0